Namouni Fouad

Insider profile

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 41% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Namouni Fouad's trades of Blueprint Medicines Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-07 2025-03-05 S Sale
94,506 -15.7%
255.72
US$1,982,075
94,506 -15.7% 255.72 US$1,982,075
2024-10-04 2024-10-03 S Sale
72,233 -29.5%
42.65
US$2,097,326
72,233 -29.5% 42.65 US$2,097,326
2024-03-11 2024-03-07 S Sale
643 +26.4%
216.01
US$2,642,350
643 +26.4% 216.01 US$2,642,350
2023-10-05 2023-10-04 S Sale
3,769 -5.7%
48.06
US$181,138
3,769 -5.7% 48.06 US$181,138
2023-03-08 2023-03-06 S Sale
63 -0.1%
44.36
US$2,795
63 -0.1% 44.36 US$2,795
2023-03-08 2023-03-06 S Sale
1,885 -2.8%
45.72
US$86,182
1,885 -2.8% 45.72 US$86,182
2022-10-05 2022-10-04 S Sale
3,477 -6.2%
67.30
US$234,002
3,477 -6.2% 67.30 US$234,002
2022-03-08 2022-03-07 S Sale
1,047 -1.8%
56.19
US$58,831
1,047 -1.8% 56.19 US$58,831
2021-10-07 2021-10-05 S Sale
3,241 -7.1%
98.18
US$318,201
3,241 -7.1% 98.18 US$318,201